The effects of a butanediol treatment on acute focal cerebral ischemia assessed by quantitative diffusion and T2 MR imaging

Magnetic Resonance Imaging

Volumn 15, Issue 9, 1997, Pages 1045-1055

  Loubinoux, Isabelle ^a,c   Volk, Andreas ^b   Borredon, Josiane ^a   Guirimand, Sophie ^a   Tiffon, Bernard ^b   Seylaz, Jacques ^a   Méric, Philippe ^a  

^a CNRS   (France)

^b INSTITUT CURIE   (France)

^c Centre Universitaire Villemin   (France)

Author keywords

Cytotoxic edema; Diffusion imaging; Ketone bodies; Magnetic resonance imaging; Middle cerebral artery occlusion; T2 imaging; Vasogenic edema

Indexed keywords

BUTANEDIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; INTRAPERITONEAL DRUG ADMINISTRATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ANIMALS; BODY WATER; BRAIN EDEMA; BRAIN ISCHEMIA; BUTYLENE GLYCOLS; CEREBRAL INFARCTION; DIFFUSION; DISEASE MODELS, ANIMAL; MAGNETIC RESONANCE IMAGING; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030853558     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(97)00141-0     Document Type: Article

References (46)

1. 1. Robertson, C.; Goodman, J.C.; Grosmann, R.G.; Claypool, M.; White, A. Dietary nonprotein calories and cerebral infarction size in rats. Stroke 23:564-568; 1992.
2. 2. Kirsch, J.R.; d'Alecy, L.G.; Mongroo, P.B. Butanediol induced ketosis increases tolerance to hypoxia in the mouse. Stroke 11:506-513; 1980.
3. 3. Kirsch, J.R.; d'Alecy, L.G. Role of tissue lactate and substrate availability in 1,3-butanediol-enhanced hypoxic survival in the mouse. Stroke 14:971-976; 1983.
4. 4. Lundy, E.F.; Dykstra, J.; Luyckx, B.; Zelenock, G.B.; d'Alecy, L.G. Reduction of neurologic deficit by 1,3-butanediol induced ketosis in levine rats. Stroke 16:855-860; 1985.
5. 5. Gueldry, S.; Marie, C.; Rochette, L.; Bralet, J. Beneficial effect of 1,3-butanediol on cerebral energy metabolism and edema following brain embolization in rats. Stroke 21: 1458-1463; 1990.
6. 6. Marie, C.; Bralet, A.M.; Bralet, J. Protective action of 1,3-butanediol in cerebral ischemia. A neurologic, histologic, and metabolic study. J. Cereb. Blood Flow Metab. 7:794-800; 1987.
7. 7. Roucher, P.; Corrèze, J.L.; Meric, Ph.; Seylaz, J.; Mispelter, J.; Tiffon, B.; Lhoste J.M. 1,3-butanediol protects the brain's energy-producing capacity during reversible ischemia. J. Cereb. Blood Flow Metab. 11; Suppl 2:S748; 1991.
8. 8. Sims, N.R.; Heward, S.L. Delayed treatment with 1,3-butanediol reduces loss of CA1 neurons in the hippocampus of rats following brief forebrain ischemia. Brain Res. 662:216-222; 1994.
9. 9. Back, T.; Hoehn-Berlage, M.; Kohno, K.; Hossmann, K.A. Diffusion nuclear magnetic resonance imaging in experimental stroke. Correlation with cerebral metabolites. Stroke 25:494-500; 1994.
10. 10. Busza, A.L.; Allen, K.L.; King, M.D.; van Bruggen, N.; Williams, S.R.; Gadian, D.G. Diffusion-weighted imaging studies of cerebral ischemia in gerbils. Potential relevance to energy failure. Stroke 23:1602-1612; 1992.
11. 11. Hossmann, K.A.; Fischer, M.; Bockhorst, K.; Hoehn-Berlage, M. NMR imaging of the apparent diffusion coefficient (ADC) for the evaluation of metabolic suppression and recovery after prolonged cerebral ischemia. J. Cereb. Blood Flow Metab. 14:723-731; 1994.
12. +-ATPase activity. J. Cereb. Blood Flow Metab. 14:332-336; 1994.
13. 13. Syková, E.; Svoboda, J.; Polák, J.; Chvátal, A. Extracellular volume fraction and diffusion characteristics during progressive ischemia and terminal anoxia in the spinal cord of the rat. J. Cereb. Blood Flow Metab. 14:301-311; 1994.
14. 14. Hasegawa, Y.; Latour, L.L.; Sotak, C.H.; Dardzinski, B.J.; Fisher, M. Temperature dependent change of apparent diffusion coefficient of water in normal and ischemic brain of rats. J. Cereb. Blood Flow Metab. 14:383-390; 1994.
15. 15. Jiang, Q.; Chopp, M.; Zhang, Z.G.; Helpern, J.A.; Ordidge, R.J.; Ewing, J.; Jiang, P.; Marchese, B.A. The effect of hypothermia on transient focal ischemia in rat brain evaluated by diffusion-and perfusion-weighted NMR imaging. J. Cereb. Blood Flow Metab. 14:732-741; 1994.
16. 16. Boisvert, D.P.J.; Handa, Y.; Allen, P.S. Proton relaxation in acute and subacute ischemic brain edema. Advances in Neurology 52:407-413; 1990.
17. 17. Boisvert, D.P.J.; Lazareff, J.A.; Allen, P.S. Quantitative magnetic resonance imaging assessment of mannitol's effect on peritumoral brain edema. Advances in Neurology 52:560; 1990.
18. 18. Kato, H.; Kogure, K.; Ohtomo, H.; Izumiyama, M.; Tobita, M.; Matsui, S.; Yamamoto, E.; Kohno, H.; Okebe, Y.; Watanabe, T. Characterization of experimental ischemic brain edema utilizing proton nuclear magnetic resonance imaging. J. Cereb. Blood Flow Metab. 6:212-221; 1986.
19. 19. Naruse, S.; Aoki, Y.; Takei, R.; Horikawa, Y.; Ueda, S. Effects of atrial natriuretic peptide on ischemic brain edema in rats evaluated by proton magnetic resonance method. Stroke 22:61-65; 1991.
20. 20. Allegrini, P.R.; Sauer, D. Application of magnetic resonance imaging to the measurement of neurodegeneration in rat brain: MRI data correlate strongly with histology and enzymatic analysis. Magn. Reson. Imaging 10:773-778; 1992.
21. 21. Gill, R.; Sibson, N.R.; Hatfield, R.H.; Burdett, N.G.; Carpenter, T.A.; Hall, L.D.; Pickard, J.D. A comparison of the early development of ischaemic damage following permanent middle cerebral artery occlusion in rats as assessed using magnetic resonance imaging and histology. J. Cereb. Blood Flow Meta. 15:1-11; 1995.
22. 22. Sauer, D.; Allegrini, P.R.; Cosenti, A.; Pataki, A.; Amacker, H.; Fagg, G.E. Characterization of the cerebroprotective efficacy of the competitive NMDA receptor antagonist CGP40116 in a rat model of focal cerebral ischemia: An in vivo magnetic resonance imaging study. J. Cereb. Blood Flow Metab. 13:595-602; 1993.
23. 2-weighted imaging: Evaluation of oedema reduction in focal cerebral ischaemia by the calcium and serotonin antagonist levemopamil. Magn. Reson. Imaging 11:401-409; 1993.
24. 24. Weber, E., Allegrini P.R., Sauer D. Assessment of infarct volume in the mouse brain: correlation of magnetic resonance imaging with morphometry. In Vivo 7:335-338; 1993.
25. 25. Lo, E.H.; Matsumoto, K.; Pierce, A.R.; Garrido, L.; Luttinger, D. Pharmacologic reversal of acute changes in diffusion-weighted magnetic resonance imaging in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 14:597-603; 1994.
26. 26. Minematsu, K.; Fisher, M.; Li, L.; Sotak, C.H. Diffusion and perfusion magnetic resonance imaging studies to evaluate a non-competitive N-methyl-d-aspartate antagonist and reperfusion in experimental stroke in rats. Stroke 24:2074-2081; 1993.
27. 27. Schuier, F.J.; Hossmann, K.A. Experimental brain infarcts in cats. II. Ischemic brain edema. Stroke 11:593-601; 1980.
28. 28. Longa, E.Z.; Weinstein, P.R.; Carlson, S.; Cummins, R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91; 1989.
29. 2 MR imaging. Stroke 28:419-427; 1997.
30. 30. Paxinos, G.; Watson, C. The Rat Brain in Stereotaxic Coordinates, 2nd Ed. New York: Academic Press; 1986.
31. 31. Volk, A; Tiffon, B.; Mispelter, J.; Lhoste, J.M. Chemical shift specific slice selection. A new method for chemical shift imaging at high magnetic field imaging. J. Magn. Reson. 71:168-174; 1987.
32. 32. Le Bihan, D.; Breton, E.; Lallemand, D.; Grenier, P.; Canabis, E.; Laval-Jeantet, M. MR imaging of intravoxel incoherent motions: Applications to diffusion and perfusion in neurologic disorders. Radiology 161:401-407; 1986.
33. 33. Le Bihan, D.; Breton, E.; Lallemand, D.; Aubin, M.L.; Vignaud, J.; Laval-Jeantet, M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497-505; 1988.
34. 34. Le Bihan, D.; Moonen, C.T.W.; Van Zijl, P.C.M.; Pekar, J.; Despres, D. Measuring random microscopic motion water in tissues with MR imaging: A cat brain study. J. Comput. Assist. Tomogr. 15:19-25; 1991.
35. 35. Dardzinski, B.J.; Sotak, C.H.; Fisher, M.; Hasegawa, Y.; Li, L.; Minematsu, K. Apparent diffusion coefficient mapping of experimental focal cerebral ischemia using diffusion-weighted echo-planar imaging. Magn. Reson. Med. 30:318-325; 1993.
36. 36. van der Toorn, A.; Verheul, H.B.; Berkelbach van Der Sprenkel, J.W.; Tulleken, C.A.F.; Nicolay, K. Changes in metabolites and tissue water status after focal ischemia in cat brain assessed with localized proton MR spectroscopy. Magn. Reson. Med. 32:685-691; 1994.
37. 37. Fox, G.; Gallacher, D.; Shevde, S.; Loftus, J.; Swayne, G. Anatomic variation of the middle cerebral artery in the Sprague-Dawley rat. Stroke 24:2087-2093; 1993.
38. 38. Kohno, K.; Hoehn-Berlage, M.; Mies, G.; Back, T.; Hossmann, K.A. Relationship between diffusion-weighted MR images, cerebral blood flow, and energy state in experimental brain infarction. Magn. Reson. Imaging 13:73-80; 1995.
39. 39. Perez-Trepichio, A.D.; Xue, M.; Ng, T.C.; Majors, A.W.; Furlan, A.J.; Awad, I.A.; Jones, S.C. Sensitivity of magnetic resonance diffusion-weighted imaging and regional relationship between the apparent diffusion coefficient and cerebral blood flow in rat focal cerebral ischemia. Stroke 26:667-674; 1995.
40. 40. Roberts, T.P.L.; Vexler, Z.; Derugin, N.; Moseley, M.E.; Kucharczyk, J. High-speed MR imaging of ischemic brain injury following stenosis of the middle cerebral artery. J. Cereb. Blood Flow Metab. 13:940-946; 1993.
41. 41. Knight, R.A.; Ordidge, R.J.; Helpern, J.A.; Chopp, M.; Rodolosi, L.C.; Pec, K.D. Temporal evolution of ischemic damage in rat brain measured by proton Nuclear Magnetic Resonance Imaging. Stroke 22:802-808; 1991.
42. 42. Knight, R.A.; Dereski, M.O.; Helpern, J.A.; Ordidge, R.J.; Chopp M. Magnetic resonance imaging assessment of evolving focal cerebral ischemia. Comparison with histopathology in rats. Stroke 25:1252-1261; 1994.
43. 43. DeVivo, D.C.; Leckie, M.P.; Ferrendelli, J.S.; McDougal, D.B. Chronic ketosis and cerebral metabolism. Ann. Neurol. 3:331-378; 1978.
44. 44. Miller, A.L.; Kiney, C.A.; Corddry, D.H.; Staton, D.M. Interactions between glucose and ketone body use by developing brain. Dev. Brain Res. 4:443-450; 1982.
45. 45. Siesjö, B.K. Brain Energy Metabolism. New York: John Wiley, and Sons. Metabolism of substrates in the brain. Regulation of metabolism. 1978: pp. 204-206.
46. 46. Kirsch, J.R.; d'Alecy, L.G. Hypoxia induced preferential ketone utilization by rat brain slices. Stroke 15:319-323; 1984.